Q4 2025 Earnings Call February 27, 2026 8:00 AM ESTCompany ParticipantsTrip TaylorJohn Treace - Founder, Chairman ...
It is a challenge for oncologists to distinguish patients with breast cancer who can forego adjuvant systemic treatment without negatively affecting survival from those who cannot. Risk prediction ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results